Tandem Diabetes Care Net Profit Margin 2012-2025 | TNDM
Tandem Diabetes Care net profit margin from 2012 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Tandem Diabetes Care Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-09-30 | $1.01B | $-0.20B | -20.16% |
| 2025-06-30 | $1.00B | $-0.21B | -20.46% |
| 2025-03-31 | $0.98B | $-0.18B | -18.72% |
| 2024-12-31 | $0.94B | $-0.10B | -10.20% |
| 2024-09-30 | $0.86B | $-0.13B | -14.85% |
| 2024-06-30 | $0.80B | $-0.14B | -17.19% |
| 2024-03-31 | $0.77B | $-0.14B | -18.42% |
| 2023-12-31 | $0.75B | $-0.22B | -29.81% |
| 2023-09-30 | $0.77B | $-0.21B | -27.07% |
| 2023-06-30 | $0.79B | $-0.23B | -28.45% |
| 2023-03-31 | $0.80B | $-0.20B | -25.66% |
| 2022-12-31 | $0.80B | $-0.10B | -11.85% |
| 2022-09-30 | $0.79B | $-0.07B | -8.60% |
| 2022-06-30 | $0.77B | $-0.01B | -1.70% |
| 2022-03-31 | $0.74B | $0.01B | 0.81% |
| 2021-12-31 | $0.70B | $0.02B | 2.28% |
| 2021-09-30 | $0.66B | $0.02B | 3.33% |
| 2021-06-30 | $0.61B | $0.01B | 1.16% |
| 2021-03-31 | $0.54B | $-0.02B | -4.43% |
| 2020-12-31 | $0.50B | $-0.03B | -6.81% |
| 2020-09-30 | $0.44B | $-0.05B | -10.93% |
| 2020-06-30 | $0.41B | $-0.04B | -10.24% |
| 2020-03-31 | $0.39B | $-0.02B | -4.31% |
| 2019-12-31 | $0.36B | $-0.03B | -6.91% |
| 2019-09-30 | $0.33B | $-0.02B | -7.27% |
| 2019-06-30 | $0.28B | $-0.06B | -19.57% |
| 2019-03-31 | $0.22B | $-0.11B | -50.45% |
| 2018-12-31 | $0.18B | $-0.12B | -66.67% |
| 2018-09-30 | $0.15B | $-0.14B | -93.20% |
| 2018-06-30 | $0.13B | $-0.12B | -92.97% |
| 2018-03-31 | $0.12B | $-0.08B | -71.30% |
| 2017-12-31 | $0.11B | $-0.07B | -68.22% |
| 2017-09-30 | $0.10B | $-0.08B | -80.21% |
| 2017-06-30 | $0.08B | $-0.09B | -112.35% |
| 2017-03-31 | $0.08B | $-0.09B | -104.82% |
| 2016-12-31 | $0.08B | $-0.08B | -98.81% |
| 2016-09-30 | $0.08B | $-0.08B | -95.24% |
| 2016-06-30 | $0.09B | $-0.07B | -79.55% |
| 2016-03-31 | $0.08B | $-0.07B | -88.89% |
| 2015-12-31 | $0.07B | $-0.07B | -100.00% |
| 2015-09-30 | $0.06B | $-0.08B | -127.42% |
| 2015-06-30 | $0.06B | $-0.08B | -131.67% |
| 2015-03-31 | $0.05B | $-0.08B | -144.44% |
| 2014-12-31 | $0.05B | $-0.08B | -158.00% |
| 2014-09-30 | $0.04B | $-0.09B | -202.38% |
| 2014-06-30 | $0.04B | $-0.08B | -216.67% |
| 2014-03-31 | $0.03B | $-0.07B | -231.25% |
| 2013-12-31 | $0.03B | $-0.06B | -217.24% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.471B | $0.940B |
| Tandem Diabetes Care, Inc. designs, develops and markets products for people with insulin-dependent diabetes. The company's flagship product, the t:slim X2 Insulin Delivery System, or t:slim X2, is based on its proprietary technology platform. Per the company, t:slim X2 is the smallest durable insulin pump available and is also the only available pump capable of remote feature updates.Tandem Diabetes also offers t:flex insulin delivery system which includes t:flex pump, its 480-unit disposable insulin cartridge, an infusion set, t:lock cartridge and infusion set products, various pump accessories along with t:slim X2 with G5 integration. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.511B | 27.63 |
| Intuitive Surgical (ISRG) | United States | $210.153B | 82.22 |
| IDEXX Laboratories (IDXX) | United States | $56.962B | 56.57 |
| Edwards Lifesciences (EW) | United States | $49.401B | 33.12 |
| IQVIA Holdings (IQV) | United States | $41.282B | 23.02 |
| Alcon (ALC) | Switzerland | $39.524B | 26.71 |
| Mettler-Toledo (MTD) | United States | $30.339B | 35.49 |
| DexCom (DXCM) | United States | $26.287B | 36.24 |
| STERIS (STE) | Ireland | $25.206B | 26.02 |
| Waters (WAT) | United States | $23.626B | 31.24 |
| Coloplast (CLPBY) | Denmark | $19.855B | 33.88 |
| Hologic (HOLX) | United States | $16.689B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.750B | 0.00 |
| Globus Medical (GMED) | United States | $12.644B | 26.54 |
| Penumbra (PEN) | United States | $12.627B | 88.83 |
| Masimo (MASI) | United States | $7.462B | 23.91 |
| Glaukos (GKOS) | United States | $6.486B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.358B | 20.20 |
| Teleflex (TFX) | United States | $4.986B | 7.94 |
| TransMedics (TMDX) | United States | $4.684B | 55.49 |
| LivaNova (LIVN) | United Kingdom | $3.517B | 19.00 |
| Alphatec Holdings (ATEC) | United States | $3.365B | 0.00 |
| Veracyte (VCYT) | United States | $3.323B | 37.87 |
| Integer Holdings (ITGR) | United States | $2.954B | 13.87 |
| Elekta AB (EKTAY) | Sweden | $2.377B | 22.24 |
| Artivion (AORT) | United States | $2.101B | 96.41 |
| UFP Technologies (UFPT) | United States | $1.986B | 26.22 |
| Nihon Kohden (NHNKY) | Japan | $1.934B | 16.88 |
| PROCEPT BioRobotics (PRCT) | United States | $1.834B | 0.00 |
| AxoGen (AXGN) | United States | $1.546B | 0.00 |
| IRadimed (IRMD) | United States | $1.259B | 59.97 |
| Integra LifeSciences Holdings (IART) | United States | $1.058B | 5.73 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.982B | 0.00 |
| SiBone (SIBN) | United States | $0.887B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.887B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.675B | 39.27 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.625B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.588B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.44 |
| NeuroPace (NPCE) | United States | $0.557B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.459B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.448B | 12.38 |
| ClearPoint Neuro (CLPT) | United States | $0.424B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.406B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.380B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.365B | 60.82 |
| RxSight (RXST) | United States | $0.363B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.301B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.296B | 2.21 |
| CVRx (CVRX) | United States | $0.213B | 0.00 |
| 908 Devices (MASS) | United States | $0.195B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.187B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.185B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.162B | 0.00 |
| Neuronetics (STIM) | United States | $0.142B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.141B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.139B | 0.00 |
| LENSAR (LNSR) | United States | $0.138B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.138B | 0.00 |
| Solana (HSDT) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.100B | 0.00 |
| Hyperfine (HYPR) | United States | $0.098B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.083B | 0.00 |
| DarioHealth (DRIO) | United States | $0.082B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.066B | 0.00 |
| Positron (POSC) | United States | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.09 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |